← Leaderboards
Catherine A Blish
Fred Hutchinson Cancer Research Center
$17,988,927
Attributed
$21,668,827
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.2M · FY2006–25$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,668,827 · 10
By mechanism
U19$5,598,964 · 1
R01$5,381,717 · 2
DP1$3,925,000 · 1
DP2$2,485,274 · 1
U01$2,123,526 · 1
R21$819,898 · 2
Top collaborators
- Clive Maurice Gray5 shared
- Heather Beryl Jaspan5 shared
- Jerome A. Zack5 shared
- Silke Paust1 shared
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Helen Horton$4,784,303
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralInfectionResponseCellsNatural Killer CellsVirusImmune ResponseImmune SystemImmuneVaccinesIn VitroT-LymphocyteCytokineImmunityHiv InfectionsPreventAntigensChronicCellular ImmunitySamplingCohortLeadAffectHiv-1
Grant awards (30)
High resolution inflammatory networks induced by HIV reservoirs in adolescents$775,460
R01 · FY2025 · AI · contact PI
Natural killer cell engineering to target the HIV reservoir$712,670
R01 · FY2025 · AI
High resolution inflammatory networks induced by HIV reservoirs in adolescents$815,573
R01 · FY2024 · AI · contact PI
Natural killer cell engineering to target the HIV reservoir$747,575
R01 · FY2024 · AI
Natural killer cell engineering to target the HIV reservoir$760,119
R01 · FY2023 · AI
Pandemic Assistance Core$5,598,964
U19 · FY2022 · AI · contact PI
Targeting natural killer cells to HIV in intravenous drug users$785,000
DP1 · FY2022 · DA · contact PI
Natural killer cell engineering to target the HIV reservoir$772,072
R01 · FY2022 · AI
Natural killer cell engineering to target the HIV reservoir$798,248
R01 · FY2021 · AI
Targeting natural killer cells to HIV in intravenous drug users$785,000
DP1 · FY2021 · DA · contact PI
Impact of HIV exposure, feeding status, and microbiome on immune ontogeny and vaccine responses in infants$420,985
U01 · FY2021 · AI · contact PI
Targeting natural killer cells to HIV in intravenous drug users$785,000
DP1 · FY2020 · DA · contact PI
Impact of HIV exposure, feeding status, and microbiome on immune ontogeny and vaccine responses in infants$423,352
U01 · FY2020 · AI · contact PI
Targeting natural killer cells to HIV in intravenous drug users$785,000
DP1 · FY2019 · DA · contact PI
Impact of HIV exposure, feeding status, and microbiome on immune ontogeny and vaccine responses in infants$422,587
U01 · FY2019 · AI · contact PI
Natural killer cells in Zika virus pathogenesis$187,570
R21 · FY2019 · AI · contact PI
Targeting natural killer cells to HIV in intravenous drug users$785,000
DP1 · FY2018 · DA · contact PI
Impact of HIV exposure, feeding status, and microbiome on immune ontogeny and vaccine responses in infants$423,056
U01 · FY2018 · AI · contact PI
Natural killer cells in Zika virus pathogenesis$232,363
R21 · FY2018 · AI · contact PI
Diagnostic signatures of Zika virus pathogenesis$180,203
R21 · FY2018 · AI · contact PI
Impact of HIV exposure, feeding status, and microbiome on immune ontogeny and vaccine responses in infants$433,546
U01 · FY2017 · AI · contact PI
Diagnostic signatures of Zika virus pathogenesis$219,762
R21 · FY2017 · AI · contact PI
Shaping Natural Killer repertoires and HIV responsiveness via antigen exposure$737,748
R56 · FY2016 · AI
Modeling the influence of sex on natural killer cell networks$98,675
DP2 · FY2015 · AI · contact PI
Harnessing natural killer cell memory to fight viruses$2,386,599
DP2 · FY2013 · AI · contact PI
Defining Immune Deficits in HIV-1 Infected Women$123,660
K08 · FY2010 · AI · contact PI
Defining Immune Deficits in HIV-1 Infected Women$123,660
K08 · FY2009 · AI · contact PI
Defining Immune Deficits in HIV-1 Infected Women$123,660
K08 · FY2008 · AI · contact PI
Defining Immune Deficits in HIV-1 Infected Women$112,860
K08 · FY2007 · AI · contact PI
Defining Immune Deficits in HIV-1 Infected Women$112,860
K08 · FY2006 · AI · contact PI